FlowCardia
acquired
acquired
Stage
About
Developer of endovascular devices for the treatment of coronary and peripheral chronic total occlusions (CTO).
Explore FlowCardia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.